Ultrasound Guided Vascular Access Site Management and Left Ventricular Pacing Are Associated with Improved Outcomes in Contemporary Transcatheter Aortic Valve Replacement: Insights from the OxTAVI Registry
Overview
Authors
Affiliations
Objectives: To identify clinical and procedural practice predictors of avoidable complications during transcatheter aortic valve replacement (TAVR).
Background: TAVR is evolving as a viable strategy for treatment of aortic stenosis (AS). Vascular complications, major bleeding, or pericardial tamponade may be influenced by procedural practice.
Methods: The Oxford TAVR (OxTAVI) prospective registry was retrospectively analyzed to identify predictors of avoidable procedural complications in a contemporary cohort of transfemoral TAVR between January 2015 and September 2018. The primary endpoint was defined as a hierarchic composite of in-hospital mortality, pericardial effusion/cardiac tamponade, major bleeding, and vascular access complications. Individual components of the primary endpoint have been analyzed separately.
Results: Five-hundred-twenty-nine patients underwent transfemoral TAVR using contemporary techniques during the study period and were enrolled in the OxTAVI registry. Female sex and high frailty were associated with a higher risk of death, major bleeding, vascular complication or pericardial tamponade. The use of ultrasound (US) guidance for vascular access management was independently associated with a reduced composite primary endpoint (OR = 0.35, CI:0.14-0.86, p = .02) after adjustment for clinical confounders, largely driven by a threefold reduction in vascular access complication (OR = 0.29, CI:0.15-0.55, p < .001). Performing rapid pacing via the left ventricle guidewire (LV-GW) was associated with a significant decrease in the risk of cardiac tamponade/pericardial effusion (OR = 0.19, CI:0.05-0.66, p = .009).
Conclusion: US-guided vascular access management and rapid pacing via the LV-GW are important determinants of reduced procedural complications during TAVR.
Naoum I, Eitan A, Sliman H, Shiran A, Adawi S, Asmer I CJC Open. 2025; 7(2):153-160.
PMID: 40060206 PMC: 11886371. DOI: 10.1016/j.cjco.2024.11.005.
Reducing Length of Hospital Stay Following Transcatheter Aortic Valve Implantation.
Gonnah A, Khokhar A, Chow J, Hartley A, Sethi R, Khawaja S J Clin Med. 2024; 13(18).
PMID: 39336919 PMC: 11431937. DOI: 10.3390/jcm13185433.
Gennari M, Maccarana A, Severgnini G, Iennaco V, Bonomi A, Capra N J Clin Med. 2024; 13(5).
PMID: 38592382 PMC: 10935327. DOI: 10.3390/jcm13051514.
Ultrasound-Guided Femoral Vascular Access for Percutaneous Coronary and Structural Interventions.
Xenogiannis I, Varlamos C, Keeble T, Kalogeropoulos A, Karamasis G Diagnostics (Basel). 2023; 13(12).
PMID: 37370923 PMC: 10297166. DOI: 10.3390/diagnostics13122028.
New Practices in Transcatheter Aortic Valve Implantation: How I Do It in 2023.
Tagliari A, Taramasso M J Clin Med. 2023; 12(4).
PMID: 36835878 PMC: 9964275. DOI: 10.3390/jcm12041342.